Treatment strategies against triple-negative breast cancer: an updated review

M Maqbool, F Bekele, G Fekadu - Breast Cancer: Targets and …, 2023 - Taylor & Francis
Triple-negative breast cancer (TNBC) is associated with an increased risk of early
recurrence and distant metastasis, as well as the development of therapeutic resistance and …

Circulating tumor cell isolation, culture, and downstream molecular analysis

S Sharma, R Zhuang, M Long, M Pavlovic, Y Kang… - Biotechnology …, 2018 - Elsevier
Circulating tumor cells (CTCs) are a major contributor of cancer metastases and hold a
promising prognostic significance in cancer detection. Performing functional and molecular …

Tumor necrosis factor α blockade: an opportunity to tackle breast cancer

MF Mercogliano, S Bruni, PV Elizalde… - Frontiers in …, 2020 - frontiersin.org
Breast cancer is the most frequently diagnosed cancer and the principal cause of mortality
by malignancy in women and represents a main problem for public health worldwide. Tumor …

RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives

M Infante, A Fabi, F Cognetti, S Gorini, M Caprio… - Journal of Experimental …, 2019 - Springer
Abstract RANKL/RANK/OPG system consists of three essential signaling molecules: i) the
receptor activator of nuclear factor (NF)-kB-ligand (RANKL), ii) the receptor activator of NF …

Targeting the NFκB signaling pathways for breast cancer prevention and therapy

W Wang, SA Nag, R Zhang - Current medicinal chemistry, 2015 - ingentaconnect.com
The activation of nuclear factor-kappaB (NFΚB), a proinflammatory transcription factor, is a
commonly observed phenomenon in breast cancer. It facilitates the development of a …

Curcumin: modulator of key molecular signaling pathways in hormone-independent breast cancer

R Farghadani, R Naidu - Cancers, 2021 - mdpi.com
Simple Summary Breast cancer remains the most commonly diagnosed cancer and the
leading cause of cancer death among females worldwide. It is a highly heterogeneous …

Positioning of proteasome inhibitors in therapy of solid malignancies

MSF Roeten, J Cloos, G Jansen - Cancer chemotherapy and …, 2018 - Springer
Targeting of the protein degradation pathway, in particular, the ubiquitin-proteasome system,
has emerged as an attractive novel cancer chemotherapeutic modality. Although …

Targeting proteotoxic stress in cancer: a review of the role that protein quality control pathways play in oncogenesis

M Ho Zhi Guang, EL Kavanagh, LP Dunne, P Dowling… - Cancers, 2019 - mdpi.com
Despite significant advances in cancer diagnostics and therapeutics the majority of cancer
unfortunately remains incurable, which has led to continued research to better understand …

Transcription factor NF-κB: an update on intervention strategies

A Panday, ME Inda, P Bagam, MK Sahoo… - Archivum immunologiae …, 2016 - Springer
The nuclear factor (NF)-κB family of transcription factors are ubiquitous and pleiotropic
molecules that regulate the expression of more than 150 genes involved in a broad range of …

Combined drug therapeutic strategies for the effective treatment of Triple Negative Breast Cancer

NKR Chalakur-Ramireddy, SB Pakala - Bioscience reports, 2018 - portlandpress.com
TNBC (Triple Negative Breast Cancer) is a subtype of breast cancer with an aggressive
phenotype which shows high metastatic capability and poor prognosis. Owing to its intrinsic …